Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Oxeltra
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxeltra 10mg modified-release tablets
0407020ADBLAFAF
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 7,220 |
|
Oxeltra 5mg modified-release tablets
0407020ADBLAAAK
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 7,195 |
|
Oxeltra 20mg modified-release tablets
0407020ADBLAHAG
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 6,373 |
|
Oxeltra 30mg modified-release tablets
0407020ADBLACAR
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 3,370 |
|
Oxeltra 40mg modified-release tablets
0407020ADBLAEAH
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 3,099 |
|
Oxeltra 15mg modified-release tablets
0407020ADBLAGAS
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 2,810 |
|
Oxeltra 60mg modified-release tablets
0407020ADBLADAQ
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 1,299 |
|
Oxeltra 80mg modified-release tablets
0407020ADBLABAI
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 838 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.